CliffBio
small molecule

SIGNIFOR LAR KIT

PASIREOTIDE PAMOATE

Loss of exclusivityMay 2028latest FDA-listed patent expiry
CompanyRecordati Rare Diseases Inc. →View the full company profile on CliffBio

Drug detail

Brand nameSIGNIFOR LAR KIT
Active ingredientPASIREOTIDE PAMOATE
StrengthEQ 40MG BASE/VIAL
Dosage formFOR SUSPENSION
RouteINTRAMUSCULAR
ModalitySmall molecule
FDA approvalDecember 2014
Marketing statusRX

Listed patents

PatentExpiresType
9351923May 2028product
7473761December 2026substance, product
7759308October 2026product

More from Recordati Rare Diseases Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SIGNIFOR LAR KIT patent cliff — loss of exclusivity May 2028 | CliffBio